Literature DB >> 22040405

Current status of cerebral glioma surgery in China.

Jin-song Wu1, Jie Zhang, Dong-xiao Zhuang, Cheng-jun Yao, Tian-ming Qiu, Jun-feng Lu, Feng-ping Zhu, Ying Mao, Liang-fu Zhou.   

Abstract

The treatment of gliomas is highly individualized. Surgery for gliomas is essentially for histological diagnosis, to alleviate mass effect, and most importantly, to favor longer survival expectancy. During the past two decades, many surgical techniques and adjuvants have been applied to glioma surgery in China, which lead to a rapid development in the field of cerebral glioma surgery. This article broadly and critically reviewed the existing studies on cerebral glioma surgery and to portrait the current status of glioma surgery in China. A literature search was conducted covering major innovative surgical techniques and adjuvants for glioma surgery in China. The following databases were searched: the Pubmed (January 1995 to date); China Knowledge Resource Integrated Database (January 1995 to date) and VIP Database for Chinese Technical Periodicals (January 1995 to date). A selection criterion was established to exclude duplicates and irrelevant studies. The outcome measures were extracted from included studies. A total of 3307 articles were initially searched. After excluded by abstracts and full texts, 69 studies conducted in the mainland of China were included and went through further analysis. The philosophy of surgical strategies for cerebral gliomas in China is undergoing tremendous change. Nowadays Chinese neurosurgeons pay more attention to the postoperative neurofunctional status of the patients. The aim of the glioma surgery is not only the more extensive tumor resection but also the maximal safety of intervention. The well balance of longer overall survival and higher quality of life should be judged with respect to each individual patient.

Entities:  

Mesh:

Year:  2011        PMID: 22040405

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  4 in total

1.  Intraoperative high-field magnetic resonance imaging combined with neuronavigation-guided resection of intracranial mesenchymal chondrosarcoma in Broca's area: a rare case report and literature review.

Authors:  Jing Yan; Jingliang Cheng; Hongwei Li; Xianzhi Liu; Yuan Zheng; Chaoyan Wang; Wenzheng Luo; Yunfei Nie; Zhengwei Li; Beibei Pang; Bo Yang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 2.  Treating malignant glioma in Chinese patients: update on temozolomide.

Authors:  Liang Chang; Jun Su; Xiuzhi Jia; Huan Ren
Journal:  Onco Targets Ther       Date:  2014-02-12       Impact factor: 4.147

3.  XGBoost algorithm and logistic regression to predict the postoperative 5-year outcome in patients with glioma.

Authors:  Zhiqiang Yan; Jiang Wang; Qiufeng Dong; Lian Zhu; Wei Lin; Xiaofan Jiang
Journal:  Ann Transl Med       Date:  2022-08

4.  Abnormal expression of menin predicts the pathogenesis and poor prognosis of adult gliomas.

Authors:  Zhan-Feng Wang; Xin-Yu Hong; Ling-Yu Zhu; Li Zhang; Huan Qiu; Yuan-Yuan Zhang; Ming-Cheng Yuan; Xing-Li Zhao; Qi-Fan Zheng; Guang-Hui Jin
Journal:  Cancer Gene Ther       Date:  2019-08-06       Impact factor: 5.987

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.